1-2 of 2
Karan Pandya
Close
Sort by
Journal Articles

Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma

Clinical Trials & Observations
Raphael E. Steiner, Steven R. Hwang, Arushi Khurana, Thomas M. Habermann, Narendranath Epperla, Kaitlin Annunzio, Pamela Blair Allen, Katelin Baird, Darina Paulino, Juan Pablo Alderuccio, Izidore S. Lossos, Kevin David, Andrew M. Evens, Karan Pandya, Steven M. Bair, Manali Kamdar, Sheeba Ba Aqeel, Pallawi Torka, Ryan Lynch, Stephen Smith, Lei Feng, Mansoor Noorani, Sairah Ahmed, Ranjit Nair, Francisco Vega, Susan Wu, Penny Fang, Chelsea C. Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja, Hun J. Lee
Journal: Blood Advances
Blood Adv (2023) 7 (24): 7485–7493.
https://doi.org/10.1182/bloodadvances.2023010700
Published: 2023
Includes: Supplemental data
Journal Articles

High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study

Clinical Trials & Observations
Adam S. Zayac, Daniel J. Landsburg, Mitchell E. Hughes, Allison M. Bock, Grzegorz S. Nowakowski, Emily C. Ayers, Mark Girton, Marie Hu, Amy K. Beckman, Shaoying Li, L. Jeffrey Medeiros, Julie E. Chang, Adam Stepanovic, Habibe Kurt, Jose Sandoval-Sus, M. Ali Ansari-Lari, Shalin K. Kothari, Anna Kress, Mina L. Xu, Pallawi Torka, Suchitra Sundaram, Stephen D. Smith, Kikkeri N. Naresh, Yasmin H. Karimi, Narendranath Epperla, David A. Bond, Umar Farooq, Mahak Saad, Andrew M. Evens, Karan Pandya, Seema G. Naik, Manali Kamdar, Bradley Haverkos, Reem Karmali, Timothy S. Oh, Julie M. Vose, Heather Nutsch, Paul G. Rubinstein, Amina Chaudhry, Adam J. Olszewski
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6381–6394.
https://doi.org/10.1182/bloodadvances.2023009731
Published: 2023
Includes: Supplemental data